Concepedia

Dose Escalation Sequencing

Dose Escalation Sequencing is a methodological framework in immuno-oncology that systematically varies the dosage levels of therapeutic agents across sequential treatment phases to optimize safety, efficacy, and immune response dynamics.

27

Publications

2.8K

Citations

216

Authors

116

Institutions

Publications per year

2017–2026

7

Parents

Publications

27

Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

John B.A.G. Haanen, Michel Obéid, Lavinia Spain et al. · Annals of Oncology · 2022 · 1.2K citations · Full text

, , +12

The Sequencing of Chemotherapy and Radiation Therapy after Conservative Surgery for Early-Stage Breast Cancer

Abram Recht, Steven E. Come, I. Craig Henderson et al. · New England Journal of Medicine · 1996 · 442 citations · Full text

, , +17

Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients

Anthony R. Mato, Brian T. Hill, Nicole Lamanna et al. · Annals of Oncology · 2017 · 224 citations · Full text

, , +16

Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre.

Manon Huizing, Giuseppe Giaccone, Laurence J. van Warmerdam et al. · Journal of Clinical Oncology · 1997 · 183 citations · Full text

, , +17

Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use

Paolo A. Ascierto, Ester Simeone, Diana Giannarelli et al. · Journal of Translational Medicine · 2012 · 124 citations · Full text

, , +17

1–5 of 27

Authors

216

  1. RG
    Rebecca Gelman

    Dana-Farber Cancer Institute, United States

    3 publications · 502 citations

    3

    h-index

  2. LA
    Laura A. Levit

    American Society of Clinical Oncology, United States

    2 publications · 49 citations

    2

    h-index

  3. JR
    Jay R. Harris

    Harvard University, United States

    2 publications · 479 citations

    2

    h-index

  4. KF
    Kathryn F. Mileham

    Levine Cancer Institute, United States

    2 publications · 49 citations

    2

    h-index

  5. MA
    Michael A. Postow

    Memorial Sloan Kettering Cancer Center, United States

    2 publications · 49 citations

    2

    h-index

1–5 of 216

Institutions

116

  1. Dana-Farber Cancer Institute

    Boston, United States

    4 h-index

    12 publications

    2.5K citations

  2. The University of Texas MD Anderson Cancer Center

    Houston, United States

    4 h-index

    7 publications

    1.3K citations

  3. Harvard University

    Cambridge, United States

    4 h-index

    13 publications

    1.6K citations

  4. Bristol-Myers Squibb (United States)

    New York, United States

    3 h-index

    3 publications

    109 citations

  5. Brigham and Women's Hospital

    Boston, United States

    3 h-index

    5 publications

    548 citations

  6. Bristol-Myers Squibb (Germany)

    Munich, Germany

    3 h-index

    13 publications

    430 citations

  7. Memorial Sloan Kettering Cancer Center

    New York, United States

    2 h-index

    2 publications

    49 citations

  8. American Society of Clinical Oncology

    Alexandria, United States

    2 h-index

    4 publications

    98 citations

1–8 of 116

Venues

  1. Journal of Clinical Oncology

    5 publications · 312 citations

    5

    h-index

  2. PubMed

    Repository · 4 publications · 74 citations

    4

    h-index

  3. 2

    h-index

  4. Annals of Oncology

    2 publications · 1.4K citations

    2

    h-index

  5. Cancer

    2 publications · 28 citations

    2

    h-index

1–5